Gavilac Oral Suspension
Oral Suspension
ACI LimitedWeight:
(500 mg+213 mg+325 mg)/10 mlbest Price:
৳ 250.00Generic
Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate
Pharmacology
The mode of action of the product is physical and does not depend on absorption into the systemic circulation. On ingestion, the product reacts rapidly with gastric acid to form a raft of Alginic acid gel having a near-neutral pH and which floats on the stomach contents quickly and effectively impeding gastro-esophageal reflux, for up to 4 hours. In severe cases, the raft itself may be refluxed into the esophagus in preference to the stomach contents and exert a demulcent effect.
Dosage Administration
For oral administration: Adult and children over 12 years:10-20 mL after meals and at bedtime, up to four times a day. Children 6 to 12 years: 5-10 mL after meals and at bedtime, up to four times a day. Children under 6 years: Not recommended. Elderly: No dosage modification is required for this age group.
Contraindications
Pregnancy: Clinical studies in more than 500 pregnant women, as well as a large amount of data from post-marketing experience, indicate no malformative nor feto/neonatal toxicity of the active ingredients. This drug can be used during pregnancy, if clinically needed. Breastfeeding: No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breastfeeding. Fertility: Pre-clinical investigations have revealed Alginate has no negative effect on parental or offspring fertility or reproduction. Clinical data do not suggest that this drug has an effect on human fertility.
Side Effects
If symptoms do not improve after 7 days, the clinical situation should be reviewed. Each 10 mL dose has a Sodium content of 141 mg (6.2 mmoL). This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment. Each 10 mL dose contains 160 mg (1.6 mmoL) of Calcium Carbonate. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi.
Pregnancy And Lactation
In the event of over dosage symptomatic treatment should be given. The patient may notice abdominal distension.
Therapeutic
Store in a cool (below 30°C) and dry place, away from light. Keep out of the reach of children. Do not refrigerate or freeze.
Storage Conditions
Store in a cool (below 30°C) and dry place, away from light. Keep out of the reach of children. Do not refrigerate or freeze.
Over The Counter Products
